Evidence Spotlight: Vibroacoustic Therapy (40 Hz) & Alzheimer’s Disease
STUDY OVERVIEW
A 3-year longitudinal clinical case study investigating whether 40Hz gamma-frequency Vibroacoustic Therapy (Rhythmic Sensory Stimulation) could help maintain cognition and reduce expected cognitive decline in a woman diagnosed with Alzheimer’s disease.
STUDY DETAILS
Study Type: Peer-reviewed longitudinal clinical case study
Participants: 1 (92-year-old woman with Alzheimer’s disease)
Frequency Used: 40Hz gamma-frequency stimulation
Study Duration: 3 years
Session Length: Initial 45-minute clinical sessions, followed by daily in-home use
WHAT THEY DID
12 intensive clinical Vibroacoustic Therapy / RSS sessions over 4 weeks
40Hz full-body auditory + vibrotactile gamma stimulation
Initial sessions delivered in clinical setting
Followed by nearly daily in-home Vibroacoustic Therapy use for 3 years
Repeated cognitive and behavioral assessments conducted
OUTCOMES MEASURED
MMSE (Mini Mental State Examination)
SLUMS cognitive testing
Memory assessments
Behavioral observations
Sleep
Caregiver interviews
Functional cognition tracking
MAJOR FINDING
After 3 years, her MMSE score remained stable at 22/30.
This is particularly significant because Alzheimer’s patients typically decline approximately 3.3 MMSE points annually.
ADDITIONAL REPORTED BENEFITS
Maintained cognitive clarity
Stabilized awareness
Reduced behavioral dysregulation
Improved sleep
Improved short-term memory indicators
Reduced frustration and tantrums
Sustained quality of life beyond expected progression patterns
CLINICAL IMPLICATIONS
This peer-reviewed longitudinal clinical case study supports Vibroacoustic Therapy / Rhythmic Sensory Stimulation as a promising modality for helping maintain cognition and potentially reduce expected cognitive decline in Alzheimer’s disease.
WHY IT MATTERS
This research suggests frequency-specific Vibroacoustic Therapy may offer meaningful support for:
Alzheimer’s support
Cognitive maintenance
Caregiver support strategies
Neurological wellness
Behavioral regulation
Nervous system support
Long-term quality of life
PUBLICATION & RESEARCH ACCESS
Published in: Music & Medicine (2017)
DOI: 10.47513/mmd.v9i3.565
Full Citation: Clements-Cortes, A., Ahonen, H., Evans, M., Tang-Wai, D., Freedman, M., & Bartel, L. (2017). Can Rhythmic Sensory Stimulation Decrease Cognitive Decline in Alzheimer’s Disease? A Clinical Case Study. Music & Medicine, 9(3), 174–177.
Research Access: Official journal abstract page / publication access:
https://mmd.iammonline.com/index.php/musmed/article/view/565